Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$371,439
-$38,308 QoQ
Shares Held
2,940
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,538
of 2,265 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hara Capital LLC holds $5,773,205 across 13 Drug Manufacturers - General names. GILD ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
67,960 | $3,258,002 | |
| 2 | AMGN |
Amgen Inc
|
2,507 | $907,834 | |
| 3 | ABBV |
AbbVie Inc.
|
3,048 | $766,998 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
2,940 | $371,439 | |
| 5 | SNY |
Sanofi
|
3,388 | $144,532 | |
| 6 | MRK |
Merck & Co., Inc.
|
852 | $109,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,360 | $78,363 | |
| 8 | LLY |
ELI LILLY & Co
|
65 | $77,962 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $371,439 | 2,940 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $409,747 | 2,940 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $368,833 | 3,005 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $333,555 | 3,005 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $333,164 | 3,005 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $336,710 | 3,005 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $277,571 | 3,005 | Shares | Sole | 2025-03-14 | |
| 2024-09-30 | $251,939 | 3,005 | Shares | Sole | 2025-04-29 | |
| 2024-06-30 | $206,173 | 3,005 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $220,848 | 3,015 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $244,245 | 3,015 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||